First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis

Tumor Treating Fields (TTFields) therapy is FDA approved and has the CE mark for treatment of newly diagnosed and recurrent glioblastoma. To our knowledge, to date TTFields therapy remains unstudied in glioblastoma patients with multiple sclerosis (MS) as a comorbidity. Here, we present a patient wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassubek, Rebecca, Mathieu, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032427/
https://www.ncbi.nlm.nih.gov/pubmed/35448029
http://dx.doi.org/10.3390/brainsci12040499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032427/
https://www.ncbi.nlm.nih.gov/pubmed/35448029
http://dx.doi.org/10.3390/brainsci12040499

Ejemplares similares